Tentori, L <br/><br/>
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Dec 1995 
 - 375-83 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF01526557  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--biosynthesis<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma--drug therapy<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytotoxicity, Immunologic--drug effects<br/>Dacarbazine--administration & dosage<br/>Drug Administration Schedule<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Immunologic Factors--pharmacology<br/>Integrin alpha6<br/>Interleukin-2--pharmacology<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasm Metastasis--prevention & control<br/>Neoplasm Proteins--biosynthesis<br/>Neoplasm Transplantation<br/>T-Lymphocytes, Cytotoxic--drug effects